pLenti-ARG2-sgRNA

Cat. No.: P743870
Disponível para encomenda
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
500μl
P743870-500μl
Sob encomenda · 8–12 semanas

468,49€

546,59€
Gravar 78,10 € (14.29%)
Enter a quantity for the sizes you want to add.

Especificações

Product Name
pLenti-ARG2-sgRNA
Product Line
Produtos biológicos
Armazenamento e envio
Condições de armazenamento de armazenamento
Store at -80°C
Enviado em
Dry ice packs + Cold packs
Estabilidade e armazenamento
Stored at -20 ℃, valid for at least 6 months;Stored at -80 ℃, valid for at least one year.

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

Tested applications, recommended conditions, and validated workflows specific to this SKU are Not specified for this item; refer to CoA/Spec Sheet.

Note: While general CRISPR/lentiviral procedures are described in the Reaction Conditions tab, only product-specific, validated protocols (e.g., exact selection antibiotic and concentration, MOI, or transfection recipe) should be followed for this SKU when available from the manufacturer’s documentation.

Biological Roles

Target gene context (ARG2; literature)

  • Function: ARG2 encodes arginase 2, a mitochondrial manganese metalloenzyme that hydrolyzes L-arginine to L-ornithine and urea. It participates in the urea/arginine–ornithine–polyamine metabolic axis, with roles in nitrogen handling and cellular redox balance.
  • Localization: Predominantly mitochondrial matrix; encoded in the nuclear genome and imported post-translationally via an N-terminal targeting sequence.
  • Isozyme complement: Distinct from ARG1 (cytosolic); ARG2 exhibits tissue-specific expression and regulation by nutrients and signaling pathways.
  • Pathway intersections: Influences nitric oxide (NO) bioavailability by competing with nitric oxide synthases for arginine; modulates polyamine synthesis through ornithine production; interfaces with proline and glutamate metabolism.

Relevance to CRISPR studies (general)

  • Knockout/knockdown of ARG2 can interrogate cellular arginine flux, mitochondrial function, and downstream effects on polyamine pools.
  • Overexpression or rescue experiments can dissect on-target phenotypes from off-target editing or compensatory metabolic rewiring.
  • Readouts: Targeted metabolomics (arginine/ornithine/urea), urea/ornithine assays, NO-related measurements, and transcriptional profiling of amino-acid metabolism genes are commonly employed.

Note: The product provides an sgRNA expression vector directed at ARG2; specific spacer sequence, species, and isoform targeting details are Not specified for this item; refer to CoA/Spec Sheet.

Buffer Applications

This product is a genetic construct rather than a buffering reagent. Conventional buffer system design (pH range, capacity, ionic strength) does not apply.

  • Handling buffer: If supplied in TE or nuclease-free water, that information is item-specific and Not specified for this item; refer to CoA/Spec Sheet.
  • For downstream cell culture work, use standard sterile PBS/DPBS and appropriate culture media as dictated by your cell line and transfection/transduction method (general guidance).
Green Alternatives

Environmental and safety considerations for CRISPR delivery (general)

  • Compared delivery modalities by “greenness” and risk profile (literature):

Comparison (general, not item-specific)

  • Lentiviral sgRNA plasmids
    • Pros: Efficient stable integration/expression; broad cell-type range.
    • Cons: Requires BSL-2 practices, generates biohazardous waste; packaging often uses transfection reagents and large plastic consumables.
  • Non-viral plasmid transfection (lipid/polymer/electroporation)
    • Pros: Avoids viral waste streams and helper plasmids; simpler logistics.
    • Cons: Lower efficiency in some primary cells; often transient.
  • RNP delivery (Cas9 protein + synthetic sgRNA)
    • Pros: No DNA; reduced off-target window; minimal integration risk; typically the lowest biohazard profile.
    • Cons: Costly; shorter activity window; may require nucleofection.

Greener practices

  • Use low-plastic workflows (reusable reservoirs where appropriate), scale-down culture volumes, and opt for serum-free or reduced-serum transfection conditions when compatible.
  • Choose endotoxin-free preparations to minimize cell stress and repeat experiments.
  • Consolidate sequencing runs and QC steps to reduce consumable use.

Trade-offs

  • While RNP approaches can be “greener” and safer, they may not match the stable expression achievable with lentiviral systems necessary for some long-term ARG2 studies.
Pharmaceutical Uses

This product is intended strictly for research use only.

  • No excipient role, compendial status, or manufacturing use is provided for this SKU. Any clinical, diagnostic, or therapeutic application is outside scope and not supported.
  • In general laboratory research, lentiviral CRISPR sgRNA plasmids are employed for target discovery and mechanistic studies, not for pharmaceutical formulation.
Physical Properties

Item-specific data

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Concentration/formulation (buffer, salt, pH): Not specified for this item; refer to CoA/Spec Sheet.
  • Extinction coefficient, A260/A280: Not specified for this item; refer to CoA/Spec Sheet.

General/literature information for plasmid DNA

  • Physical state: Aqueous solution (commonly in TE or nuclease-free water) or lyophilized solid; exact state for this item is Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Plasmid DNA is water-soluble; insoluble in most organic solvents (literature).
  • Stability: Stable when frozen at −20 to −80°C; repeated freeze–thaw may shear DNA (literature).
  • UV absorbance: DNA λmax ≈ 260 nm; A260 of 1.0 ≈ 50 µg/mL for dsDNA (literature).
  • pH sensitivity: Prolonged exposure to acidic pH can depurinate DNA; EDTA chelation helps protect from nucleases (literature).

Non-applicable physicochemical properties

  • Boiling point, melting point (as for small molecules), density, logP, refractive index: Not applicable to high–molecular weight plasmid DNA; Not specified for this item; refer to CoA/Spec Sheet.

Practical notes (general)

  • Avoid metal-ion contamination and nucleases; use nuclease-free plasticware and buffers.
  • For accurate quantitation, use A260 with baseline correction or fluorometric dsDNA dyes; verify integrity by agarose gel or capillary electrophoresis.
Quality and Grades

Item-specific quality information

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Sequence verification, endotoxin level, host strain, and antibiotic resistance marker: Not specified for this item; refer to CoA/Spec Sheet.

Context and interpretation (general/literature)

  • Plasmid QC practices commonly include: full plasmid sequencing or at minimum sgRNA spacer verification; restriction digest patterns; endotoxin testing for cell culture suitability; and confirmation of antibiotic resistance phenotype.
  • For CRISPR applications, spacer sequence accuracy is critical; even single-nucleotide deviations can impact on-target efficiency.
  • Low-endotoxin preparations are preferred for sensitive primary cells and for high-efficiency transfection prior to lentiviral packaging.

Implications for use

  • If the item is provided as a glycerol stock or bacterial stab, users typically re-streak, mini-/maxi-prep, and verify insert by Sanger sequencing before critical experiments (best practice; not item-specific).
  • If supplied as purified plasmid, verify concentration (A260/fluorometric) and integrity (gel) upon receipt.

Documentation

  • For precise attributes (vector map, antibiotic marker, selection cassette, sgRNA sequence), consult the product CoA/Spec Sheet. Do not substitute general expectations for item-specific specifications.
Reaction and Applications

Use domain (expanded from product name; general/literature)

  • Gene editing: Designed to express an sgRNA targeting the human ARG2 locus for CRISPR/Cas9-mediated gene knockout or transcriptional modulation when paired with Cas9 or dCas9 effectors.
  • Lentiviral delivery: pLenti backbones enable packaging into replication-defective lentiviral particles using helper plasmids (gag/pol, rev, VSV-G) for stable delivery to dividing and non-dividing cells (BSL-2).
  • Functional genomics: Supports target validation, pathway dissection, and loss-of-function studies for ARG2-related biology.

Typical workflows (general)

  • Cloning/verification: Confirm spacer sequence by Sanger sequencing; optional Gibson/Golden Gate to swap spacers if needed.
  • Transient vs stable: Transfect plasmid directly into cells expressing Cas9, or package into lentivirus for stable delivery and selection.
  • Selection/readouts: If vector contains an antibiotic marker or reporter (not specified here), apply appropriate selection and quantify editing by T7E1, ICE/TIDE, amplicon NGS, or targeted qPCR.

Practical tips (general)

  • Spacer design: Use on-target/off-target scoring tools; favor NGG-adjacent protospacers for SpCas9; avoid SNP-rich regions.
  • Controls: Include non-targeting and known-positive control sgRNAs; rescue by ARG2 cDNA re-expression can confirm on-target phenotypes.
  • Multiplexing: Dual sgRNAs can create defined deletions; ensure vector capacity and promoter compatibility.

Item-specific activity claims or performance data are not provided for this SKU; consult CoA/Spec Sheet for exact design elements.

Reaction Conditions

Item-specific reaction/operational parameters are not provided. The following are general, literature-based guidelines for lentiviral CRISPR workflows targeting genes such as ARG2.

General conditions (literature)

  • Plasmid propagation: Transform into a recombination-deficient E. coli strain; grow at 30–37°C; select with the appropriate antibiotic. Prepare endotoxin-reduced DNA for mammalian use.
  • Transfection for packaging: HEK293T cells at 60–80% confluence; co-transfect transfer plasmid with helper plasmids (e.g., psPAX2/pMD2.G) using a lipid/polymer transfection reagent per vendor instructions. Replace medium after 6–18 h; collect supernatant 48–72 h post-transfection.
  • Transduction: Add filtered viral supernatant with polybrene (e.g., 2–8 µg/mL, cell line dependent) to target cells; spinoculation can increase MOI. Select stably transduced cells based on vector’s selectable marker (not specified here).
  • Editing assessment: Harvest genomic DNA 3–7 days post-transduction (or later for stable lines); amplify target site and quantify INDELs by TIDE/ICE or NGS.

Typical ranges (illustrative, not item-specific)

  • MOI: 0.3–5 depending on desired single-copy vs multi-copy integration.
  • Temperature/CO2: 37°C, 5% CO2 for mammalian culture; biosafety level 2 for lentiviral steps.

Consult the item’s CoA/Spec Sheet for exact vector features, selection conditions, and any tested performance data.

Safety and Handling

Authoritative safety information should be obtained from the product-specific SDS.

Item-specific hazard data

  • GHS Classification / Signal Word / H-Statements / Pictograms: Not specified for this item; refer to SDS.

General biosafety considerations (literature/guidance)

  • Nature of material: Plasmid DNA encoding sgRNA is not infectious by itself. If used for lentiviral packaging, downstream work with replication-defective lentiviral particles typically requires BSL-2 containment and institutional biosafety approval.
  • PPE: Lab coat, gloves (nitrile), and eye protection are standard. Use biological safety cabinet (Class II) for virus production and handling of transduction steps.
  • Incompatibilities: Avoid nucleases (DNase) and microbial contamination. Keep away from strong acids/bases that can hydrolyze DNA.
  • Hygiene: Work with nuclease-free reagents and dedicated pipettes. Decontaminate surfaces with 10% bleach followed by 70% ethanol after lentiviral work.
  • Waste: Treat lentiviral waste as biohazard; follow institutional procedures for deactivation (e.g., bleach) prior to disposal.

First-aid overview (general)

  • Skin/eye contact with buffers: Rinse with water. Seek medical attention if irritation persists.
  • Ingestion/inhalation: Not intended for human/animal use. If exposure occurs, seek medical attention and provide SDS.

Transport/storage risks

  • Maintain cold chain as provided: shipped on dry ice/cold packs; store at −80°C upon receipt to preserve integrity.
Solvent Selection

This product is a plasmid DNA construct, typically supplied in an aqueous buffer or as a bacterial stock. Conventional solvent-selection guidance for small-molecule solutes is not applicable.

  • Applicable medium: Nuclease-free water or TE buffer are standard for plasmid handling (literature). Presence/absence of specific buffer components for this SKU is Not specified for this item; refer to CoA/Spec Sheet.
  • Miscibility/polarity: DNA is hydrophilic and insoluble in most organic solvents; avoid alcohol precipitation unless intentionally concentrating/purifying (literature).
  • Practical note: For transfection, follow reagent manufacturer guidance for complexation buffers; for lentiviral packaging, culture media compatibility, serum presence, and transfection reagent choice govern performance more than solvent polarity.

For solvent-like comparisons (not applicable): Traditional dielectric constant, Hansen parameters, or UV cutoff data are not relevant for this biological construct.

Storage and Reconstitution

Item-specific

  • Storage Conditions: Store at −80°C.
  • Shipping: Shipped on dry ice packs + cold packs, maintain cold chain upon receipt.
  • Reconstitution buffer, concentration, aliquot size, and thawing instructions: Not specified for this item; refer to CoA/Spec Sheet.

General handling guidance (literature)

  • If received as purified plasmid: Thaw on ice, briefly spin, and keep on ice during use. Aliquot to avoid repeated freeze–thaw; store working aliquots at −20°C and master stock at −80°C.
  • If received as bacterial glycerol stock: Streak onto selective agar, incubate 12–18 h, pick a single colony for miniprep; verify insert sequence before scale-up. Store the original glycerol stock at −80°C.
  • If lyophilized: Reconstitute with nuclease-free water or TE to desired concentration (e.g., 50–200 ng/µL); allow to fully dissolve on ice before use.
  • Avoid repeated freeze–thaw cycles; use low-adhesion, nuclease-free tubes and tips; include EDTA (0.1–1 mM) in long-term storage buffers to chelate divalent cations.

Always consult the product’s CoA/Spec Sheet for any item-specific storage buffer composition and reconstitution instructions.

Structure and Identity

Overview: pLenti-ARG2-sgRNA is a lentiviral CRISPR/Cas9 guide RNA plasmid designed to express a single guide RNA (sgRNA) targeting the ARG2 gene (arginase 2).

Item-specific identifiers

  • CAS: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey / SMILES / CID: Not applicable to plasmid DNA constructs.

Structural features (general, literature)

  • Backbone: Typical pLenti vectors include a 5′ and 3′ LTR, packaging signal (Psi), and selectable markers; exact map/features for this SKU are Not specified for this item; refer to CoA/Spec Sheet.
  • Functional cassette: U6 or H1 promoter–driven sgRNA scaffold with a gene-specific spacer sequence for ARG2. The specific spacer sequence and scaffold version are Not specified for this item; refer to CoA/Spec Sheet.
  • Optional elements often present in pLenti CRISPR systems (literature): antibiotic resistance marker (e.g., puromycin or blasticidin), fluorescent reporter, origin(s) of replication for E. coli, and WPRE/CMV promoters. Presence/absence for this item is Not specified for this item; refer to CoA/Spec Sheet.

2D description in words (general)

  • Circular double-stranded DNA plasmid comprising modular transcription units: a Pol III promoter driving the sgRNA (spacer + tracrRNA scaffold), flanked by lentiviral cis-acting sequences to enable packaging into VSV-G–pseudotyped lentiviral particles when co-transfected with helper plasmids. No small-molecule stereochemistry applies.
Synthetic Utility

Not a small-molecule building block; conventional synthetic utility (as a reagent/intermediate) does not apply.

Molecular biology utility (general)

  • Vector engineering: Backbone can serve as a template for cloning alternative ARG2-targeting spacers or multiplex sgRNA cassettes via Golden Gate or Gibson assembly.
  • Modular swaps: Promoter or selection cassettes can be exchanged if compatible restriction sites or homology arms are available (item-specific map Not specified for this item; refer to CoA/Spec Sheet).
  • Readout integration: Reporter elements or barcodes can be inserted for pooled screening or lineage tracing, subject to vector capacity constraints (literature).

Note: Do not infer the presence of specific cloning sites or cassettes for this SKU without consulting the provided plasmid map/CoA.

Target Specificity

Item-specific targeting details

  • sgRNA spacer sequence, PAM context, species/isoform targeting, and verified on-target site: Not specified for this item; refer to CoA/Spec Sheet.

General notes (literature)

  • ARG2 targeting: Effective sgRNAs typically target early constitutive exons shared by major transcripts to maximize knockout probability; PAM compatibility (e.g., NGG for SpCas9) is required.
  • Off-target risk: In silico design should minimize sequence similarity to non-target loci; empirical validation via amplicon sequencing at predicted off-targets is recommended.

This section is not analogous to antibody target reactivity (antigen/epitope/clone/isotype) because the product is a nucleic-acid vector rather than an antibody.

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.